Taurus Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $25.8M | Sell |
51,806
-490
| -0.9% | -$265K | 2.61% | 12 |
|
|
2024
Q4 | $27.2M | Buy |
52,296
+477
| +0.9% | +$262K | 2.65% | 12 |
|
|
2024
Q3 | $32.1M | Sell |
51,819
-159
| -0.3% | -$94.1K | 3.12% | 9 |
|
|
2024
Q2 | $28.7M | Sell |
51,978
-576
| -1% | -$330K | 2.91% | 9 |
|
|
2024
Q1 | $30.5M | Sell |
52,554
-1,540
| -3% | -$864K | 3.09% | 9 |
|
|
2023
Q4 | $28.7M | Sell |
54,094
-245
| -0.5% | -$119K | 3.1% | 9 |
|
|
2023
Q3 | $27.5M | Buy |
54,339
+230
| +0.4% | +$123K | 3.34% | 9 |
|
|
2023
Q2 | $28.2M | Sell |
54,109
-728
| -1% | -$393K | 3.28% | 8 |
|
|
2023
Q1 | $31.6M | Sell |
54,837
-16,963
| -24% | -$9.56M | 3.86% | 5 |
|
|
2022
Q4 | $39.5M | Sell |
71,800
-923
| -1% | -$489K | 5.02% | 4 |
|
|
2022
Q3 | $36.9M | Sell |
72,723
-4,365
| -6% | -$2.44M | 4.94% | 4 |
|
|
2022
Q2 | $41.9M | Sell |
77,088
-1,806
| -2% | -$994K | 5.17% | 3 |
|
|
2022
Q1 | $46.6M | Sell |
78,894
-2,453
| -3% | -$1.41M | 4.69% | 5 |
|
|
2021
Q4 | $54.3M | Sell |
81,347
-184
| -0.2% | -$115K | 5.12% | 4 |
|
|
2021
Q3 | $46.6M | Sell |
81,531
-1,205
| -1% | -$661K | 4.85% | 5 |
|
|
2021
Q2 | $41.7M | Buy |
82,736
+645
| +0.8% | +$304K | 4.36% | 5 |
|
|
2021
Q1 | $37.5M | Sell |
82,091
-1,575
| -2% | -$752K | 4.32% | 4 |
|
|
2020
Q4 | $39M | Sell |
83,666
-6,946
| -8% | -$3.26M | 4.66% | 4 |
|
|
2020
Q3 | $40M | Sell |
90,612
-225
| -0.2% | -$93K | 4.95% | 4 |
|
|
2020
Q2 | $32.9M | Sell |
90,837
-261
| -0.3% | -$87.5K | 4.57% | 4 |
|
|
2020
Q1 | $25.8M | Buy |
91,098
+70
| +0.1% | +$22.1K | 4.29% | 5 |
|
|
2019
Q4 | $29.6M | Sell |
91,028
-696
| -0.8% | -$211K | 3.85% | 4 |
|
|
2019
Q3 | $26.7M | Sell |
91,724
-435
| -0.5% | -$125K | 3.8% | 5 |
|
|
2019
Q2 | $27.1M | Sell |
92,159
-1,125
| -1% | -$310K | 3.69% | 4 |
|
|
2019
Q1 | $25.5M | Sell |
93,284
-2,495
| -3% | -$621K | 3.57% | 5 |
|
|
2018
Q4 | $21.4M | Buy |
95,779
+25
| +0% | +$5.87K | 3.43% | 7 |
|
|
2018
Q3 | $23.4M | Sell |
95,754
-325
| -0.3% | -$74.8K | 3.16% | 6 |
|
|
2018
Q2 | $19.9M | Buy |
96,079
+12,290
| +15% | +$2.61M | 2.91% | 8 |
|
|
2018
Q1 | $17.3M | Sell |
83,789
-1,935
| -2% | -$406K | 2.6% | 11 |
|
|
2017
Q4 | $16.3M | Sell |
85,724
-4,077
| -5% | -$781K | 2.39% | 12 |
|
|
2017
Q3 | $17M | Sell |
89,801
-650
| -0.7% | -$118K | 2.64% | 8 |
|
|
2017
Q2 | $15.8M | Sell |
90,451
-720
| -0.8% | -$121K | 2.47% | 11 |
|
|
2017
Q1 | $14M | Sell |
91,171
-1,215
| -1% | -$186K | 2.3% | 13 |
|
|
2016
Q4 | $13M | Sell |
92,386
-2,580
| -3% | -$380K | 2.37% | 17 |
|
|
2016
Q3 | $15.1M | Sell |
94,966
-1,097
| -1% | -$169K | 2.73% | 12 |
|
|
2016
Q2 | $14.2M | Sell |
96,063
-70
| -0.1% | -$10.3K | 2.49% | 13 |
|
|
2016
Q1 | $13.6M | Buy |
96,133
+175
| +0.2% | +$23.5K | 2.52% | 15 |
|
|
2015
Q4 | $13.6M | Sell |
95,958
-327
| -0.3% | -$43.6K | 2.55% | 13 |
|
|
2015
Q3 | $11.8M | Buy |
96,285
+1,270
| +1% | +$165K | 2.27% | 17 |
|
|
2015
Q2 | $12.3M | Sell |
95,015
-835
| -0.9% | -$109K | 2.24% | 14 |
|
|
2015
Q1 | $12.9M | Buy |
95,850
+245
| +0.3% | +$31.6K | 2.4% | 12 |
|
|
2014
Q4 | $12M | Sell |
95,605
-408
| -0.4% | -$49.6K | 2.15% | 17 |
|
|
2014
Q3 | $11.7M | Sell |
96,013
-700
| -0.7% | -$85.1K | 2.27% | 12 |
|
|
2014
Q2 | $11.4M | Buy |
96,713
+4,720
| +5% | +$556K | 2.21% | 9 |
|
|
2014
Q1 | $11.1M | Sell |
91,993
-575
| -0.6% | -$68.4K | 2.29% | 7 |
|
|
2013
Q4 | $10.3M | Sell |
92,568
-770
| -0.8% | -$76.6K | 2.12% | 9 |
|
|
2013
Q3 | $8.6M | Sell |
93,338
-2,800
| -3% | -$253K | 1.99% | 17 |
|
|
2013
Q2 | $8.14M | Buy |
+96,138
| New | +$8M | 1.93% | 13 |
|
Other funds holding TMO
Taurus Asset Management's TMO Position: Q1 2025 in Review
Taurus Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 0.94% in Q1 2025, selling an estimated $265K and leaving 51,806 shares worth $25.8M. The position accounts for 2.61% of the portfolio, ranked #12.
Taurus Asset Management first reported a position in TMO in Q2 2013 and has held it in 48 quarters since. The position peaked at $54.3M in Q4 2021. 2,571 funds tracked by Wall St. Rank hold TMO as of Q1 2025.
- Taurus Asset Management held 51,806 shares of Thermo Fisher Scientific worth $25.8M as of Q1 2025.
- Taurus Asset Management sold 490 Thermo Fisher Scientific shares in Q1 2025, an estimated $265K.
- Thermo Fisher Scientific made up 2.61% of Taurus Asset Management's portfolio in Q1 2025, its #12 holding.
- Taurus Asset Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 48 quarters since.
- Taurus Asset Management's Thermo Fisher Scientific position peaked at $54.3M in Q4 2021.
- 2,571 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.
Based on Taurus Asset Management's 13F filing for Q1 2025, filed 13 May 2025.